Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.

Whitney CG, Goldblatt D, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S172-81. doi: 10.1097/INF.0000000000000076. Review.

2.

Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.

Loo JD, Conklin L, Fleming-Dutra KE, Knoll MD, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S161-71. doi: 10.1097/INF.0000000000000084. Review.

3.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.

Fleming-Dutra KE, Conklin L, Loo JD, Knoll MD, Park DE, Kirk J, Goldblatt D, Whitney CG, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S152-60. doi: 10.1097/INF.0000000000000083. Review.

4.

Pneumococcal polysaccharide-protein CRM197 conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule.

Fritzell B, Fletcher MA.

Expert Rev Vaccines. 2011 Mar;10(3):263-90. doi: 10.1586/erv.11.11.

PMID:
21434795
5.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.

Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S140-51. doi: 10.1097/INF.0000000000000082. Review.

6.

Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.

van Gils EJ, Veenhoven RH, Hak E, Rodenburg GD, Bogaert D, Ijzerman EP, Bruin JP, van Alphen L, Sanders EA.

JAMA. 2009 Jul 8;302(2):159-67. doi: 10.1001/jama.2009.975.

PMID:
19584345
7.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children.

Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S109-18. doi: 10.1097/INF.0000000000000078. Review.

8.
9.

Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules.

Loo JD, Conklin L, Deloria Knoll M, Fleming-Dutra KE, Park DE, Kirk J, Johnson TS, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S182-7. doi: 10.1097/INF.0000000000000085. Review.

10.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.

Deloria Knoll M, Park DE, Johnson TS, Chandir S, Nonyane BA, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S119-29. doi: 10.1097/INF.0000000000000079. Review.

11.

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.

Spijkerman J, Veenhoven RH, Wijmenga-Monsuur AJ, Elberse KE, van Gageldonk PG, Knol MJ, de Melker HE, Sanders EA, Schouls LM, Berbers GA.

JAMA. 2013 Sep 4;310(9):930-7. doi: 10.1001/jama.2013.228052.

PMID:
24002279
12.

The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.

Dagan R, Givon-Lavi N, Porat N, Greenberg D.

Vaccine. 2012 Jul 20;30(34):5132-40. doi: 10.1016/j.vaccine.2012.05.059. Epub 2012 Jun 6.

PMID:
22683519
13.

Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens.

Mahon BE, Hsu K, Karumuri S, Kaplan SL, Mason EO Jr, Pelton SI; U.S. Pediatric Multicenter Pneumococcal Surveillance Group; Massachusetts Department of Public Health Epidemiologists.

Vaccine. 2006 Mar 24;24(14):2514-20. Epub 2005 Dec 27.

PMID:
16417951
14.

Economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Korea.

Sohn HS, Suh DC, Jang E, Kwon JW.

J Manag Care Pharm. 2010 Jan-Feb;16(1):32-45.

15.

Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.

Vučina VV, Filipović SK, Kožnjak N, Stamenić V, Clark AD, Mounaud B, Blau J, Hoestlandt C, Kaić B.

Vaccine. 2015 May 7;33 Suppl 1:A209-18. doi: 10.1016/j.vaccine.2014.12.043.

PMID:
25919163
16.

Pneumococcal vaccination in Europe: schedule adherence.

Gervaix A, Ansaldi F, Brito-Avô A, Azzari C, Knuf M, Martinón-Torres F, Tuerlinckx D, Tin Htar MT, Syrogiannopoulos GA.

Clin Ther. 2014 May;36(5):802-12.e1. doi: 10.1016/j.clinthera.2014.03.001. Epub 2014 Apr 18.

PMID:
24746990
17.

Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.

Madhi SA, Cohen C, von Gottberg A.

Vaccine. 2012 Sep 7;30 Suppl 3:C21-7. doi: 10.1016/j.vaccine.2012.05.055. Review.

PMID:
22939016
18.

Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada.

Deceuninck G, De Wals P, Boulianne N, De Serres G.

Pediatr Infect Dis J. 2010 Jun;29(6):546-9. doi: 10.1097/INF.0b013e3181cffa2a.

PMID:
20125062
19.

Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.

Tyo KR, Rosen MM, Zeng W, Yap M, Pwee KH, Ang LW, Shepard DS.

Vaccine. 2011 Sep 2;29(38):6686-94. doi: 10.1016/j.vaccine.2011.06.091. Epub 2011 Jul 13.

PMID:
21745516
20.

Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis.

Scott P, Rutjes AW, Bermetz L, Robert N, Scott S, Lourenço T, Egger M, Low N.

Vaccine. 2011 Dec 6;29(52):9711-21. doi: 10.1016/j.vaccine.2011.07.042. Epub 2011 Aug 5. Review.

PMID:
21821080

Supplemental Content

Support Center